Thyrocare Technologies Limited (THYROCARE) - Total Assets
Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) holds total assets worth Rs7.47 Billion INR (≈ $80.81 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Thyrocare Technologies Limited (THYROCARE) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Thyrocare Technologies Limited - Total Assets Trend (2011–2026)
This chart illustrates how Thyrocare Technologies Limited's total assets have evolved over time, based on quarterly financial data.
Thyrocare Technologies Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Thyrocare Technologies Limited's total assets of Rs7.47 Billion consist of 49.8% current assets and 50.2% non-current assets. Also see Thyrocare Technologies Limited market capitalisation for the company's overall valuation and market capitalisation.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 9.1% |
| Accounts Receivable | Rs738.80 Million | 9.9% |
| Inventory | Rs484.60 Million | 6.5% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs34.90 Million | 0.5% |
| Goodwill | Rs1.08 Billion | 14.5% |
Asset Composition Trend (2011–2026)
This chart illustrates how Thyrocare Technologies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See THYROCARE share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Thyrocare Technologies Limited's current assets represent 49.8% of total assets in 2026, a decrease from 55.4% in 2011.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2026, down from 39.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 4.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 14.5% of total assets.
Thyrocare Technologies Limited Competitors by Total Assets
Key competitors of Thyrocare Technologies Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Wellfully Ltd
AU:WFL
|
Australia | AU$3.51 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Cryosite Ltd
AU:CTE
|
Australia | AU$26.55 Million |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
Thyrocare Technologies Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.39 | 2.77 | 2.50 |
| Quick Ratio | 2.95 | 2.17 | 2.26 |
| Cash Ratio | 0.00 | 0.15 | 0.00 |
| Working Capital | Rs2.62 Billion | Rs2.16 Billion | Rs1.43 Billion |
Thyrocare Technologies Limited - Advanced Valuation Insights
This section examines the relationship between Thyrocare Technologies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 14.72 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 7.9% |
| Total Assets | Rs7.47 Billion |
| Market Capitalization | $1.07 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Thyrocare Technologies Limited's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Thyrocare Technologies Limited's assets grew by 7.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Thyrocare Technologies Limited (2011–2026)
The table below shows the annual total assets of Thyrocare Technologies Limited from 2011 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs7.47 Billion ≈ $80.81 Million |
+7.86% |
| 2025-03-31 | Rs6.93 Billion ≈ $74.92 Million |
+7.59% |
| 2024-03-31 | Rs6.44 Billion ≈ $69.63 Million |
+1.76% |
| 2023-03-31 | Rs6.33 Billion ≈ $68.43 Million |
+4.12% |
| 2022-03-31 | Rs6.08 Billion ≈ $65.72 Million |
+11.33% |
| 2021-03-31 | Rs5.46 Billion ≈ $59.03 Million |
+16.29% |
| 2020-03-31 | Rs4.69 Billion ≈ $50.76 Million |
-1.14% |
| 2019-03-31 | Rs4.75 Billion ≈ $51.34 Million |
-0.89% |
| 2018-03-31 | Rs4.79 Billion ≈ $51.80 Million |
+9.91% |
| 2017-03-31 | Rs4.36 Billion ≈ $47.13 Million |
+6.38% |
| 2016-03-31 | Rs4.10 Billion ≈ $44.30 Million |
+24.31% |
| 2015-03-31 | Rs3.30 Billion ≈ $35.64 Million |
+34.12% |
| 2014-03-31 | Rs2.46 Billion ≈ $26.57 Million |
+25.03% |
| 2013-03-31 | Rs1.97 Billion ≈ $21.25 Million |
+43.38% |
| 2012-03-31 | Rs1.37 Billion ≈ $14.82 Million |
+35.80% |
| 2011-03-31 | Rs1.01 Billion ≈ $10.92 Million |
-- |
About Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical an… Read more